0A8S.LSE Sintx Technologies, Inc.
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0A8S.LSE undervalued?
Graham numberThe Graham number of Sintx Technologies, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sintx Technologies, Inc. fundamental analysis
No fundamental analysis for Sintx Technologies, Inc. yet.
Sintx Technologies, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials…
Full company profileFinancial statements of Sintx Technologies, Inc. are not available yet.
Sintx Technologies, Inc. dividends
Sintx Technologies, Inc. has not paid dividends in the last 4 fiscal years.
Last stock split: 0.005:1 on May 28, 2024.
Who owns Sintx Technologies, Inc.
- Insiders 19.52%
- Institutions 12.81%
- Public & others 67.67%
- Free float 5.48M
Sintx Technologies, Inc. company profile
- Company name
- Sintx Technologies, Inc.
- Ticker
- 0A8S.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 32
- Fiscal year end
- December
- Address
- 1885 West 2100 South, Salt Lake City, UT, United States, 84119
- Phone
- 801 839 3500
- Website
- sintx.com
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY" technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Sintx Technologies, Inc. management
5- Mr. Eric K. OlsonCEO & Chairman of the Board · born 1963
- Mr. Kevin TraskChief Financial Officer · born 1986
- Mr. Gregg Richard HonigblumChief Investment Officer & Director · born 1963
- Mr. Ryan ElmorePresident · born 1975
- Mr. Kevin J. Ontiveros Esq.Chief Legal Officer · born 1960